Targeting the ERK Pathway Reduces Liver Metastasis of Smad4-Inactivated Colorectal Cancer

Cancer Biology and Therapy - United States
doi 10.4161/cbt.26427
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

PEA15 Promotes Liver Metastasis of Colorectal Cancer by Upregulating the ERK/MAPK Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

Loss of Smad4 Expression Predicts Liver Metastasis in Human Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2007English

Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis

PLoS ONE
Multidisciplinary
2017English

No SMAD4 Hypermethylation in Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2000English

Clinicopathological Study of Colorectal Cancer With Synchronous Liver Metastasis

The journal of the Japanese Practical Surgeon Society
1991English

Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions

Cellular and Molecular Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

Clinicopathological Study on Colorectal Cancer With Synchronous Liver Metastasis.

Nippon Daicho Komonbyo Gakkai Zasshi
1991English

Antimetastatic Role of Smad4 Signaling in Colorectal Cancer

Gastroenterology
HepatologyGastroenterology
2010English

Perioperative Chemotherapy With Bevacizumab and Liver Resection for Colorectal Cancer Liver Metastasis

HPB
HepatologyGastroenterology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy